Skip to content

Case Study 投資案例:Great Bay Bio 大灣生物

  • by
Case Study 投資案例:Great Bay Bio 大灣生物

Video by Invest Hong Kong via YouTube
Source
Case Study 投資案例:Great Bay Bio 大灣生物

Synergy at the Crossroads: Fusing Bioprocessing and AI for Innovative Solutions
結合生物製程與人工智能 開發創新解決方案

Headquartered in Hong Kong, Great Bay Bio (GBB) is an innovative biotechnology company that aims to enhance bioprocessing efficiency using artificial intelligence (AI) and cutting-edge technologies. Its mission is to elevate drug development efficiency and success rates, while also propelling progress in various bioprocessing sectors including synthetic biology, in vitro diagnostics (IVD), and cell and gene therapy (CGT). Recently, GBB has introduced multiple proprietary AI platforms for cell line development and cell culture media development technology services. As a trailblazer in the field, the company has secured 26 patents for its AI-powered bioprocessing solutions and has forged strategic collaborations with over 20 prominent companies at home and abroad.
大灣生物是一間總部位於香港的創新生物科技公司,致力利用人工智能及先進科技提高生物製程效率。公司旨在改善藥物研發效率及成功率,同時促進各個生物製程領域的發展,包括合成生物學、體外診斷以及細胞和基因療法。近年,大灣生物推出多個專屬的人工智能平台,提供細胞系開發及細胞培養基開發技術的服務。作為行業先驅,大灣生物已就人工智能生物製程解決方案取得26項專利,並與20多間知名的國內外企業建立策略合作關係。

——————————————————
Interested in setting up and expanding your business to HK?
Like our videos and subscribe to our YouTube Channel for latest updates

Visit us at: https://investhk.gov.hk
InvestHK on LinkedIn: https://www.linkedin.com/company/invest-hong-kong/
InvestHK on Twitter: https://twitter.com/InvestHK
InvestHK on WeChat: @InvestHK_HK
InvestHK on Weibo: https://e.weibo.com/investhk

Go to Source